Skip to content

Dr. E. MULLIEZ

Active Private limited companyfounded 2006active for 20 yearsRijselstraat 88, 8900 YpresKBO/BCE: BE 0880.650.726 #9 company by equity in Ypres, Health and social work sector

Lifetime

19 annual accounts with figures on one time axis
peak of €614,512 in 2022
€530,534▲ 5.6%
peak of €948,706 in 2015
€386,245▲ 9.3%
peak of €3.3m in 2018
€3.2m▲ 3.8%
€269,507▼ 32.5%
Board1 name since 2006
1 director
Documentsfilings and deeds
28-09-20262 days before the deadline
2026micro format
Dividend €269,819Debts from €399,018 to €269,507

Key points

from the 2026 annual accounts

Equity

€3.2m ▲ 3.8%
3.12025+0.4Profit-0.3Dividend3.22026

Dr. E. MULLIEZ paid out €269,819 in dividends. That is 70% of the 2026 profit.

Filings

19 annual accounts since 2008
deadline2010201520202025

Six of the last ten came late. The 2021 accounts came in latest, 28 days after the end of the period.

Position in the sector

€386,245

Higher net result than 95% of companies in human health. Sector median €64,640 · 563 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as Dr. E. MULLIEZ has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for Dr. E. MULLIEZ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 31-03-2006
  • deed of 16-01-2014
Board & ownership

Recent changes

Amendment of the articles · Legal-form change · Resignations & appointments Board composition: (statutory director) · Gazette deed
Capital decrease of €954,000 to €25,000 The capital fell from €979,000 to €25,000 · Gazette deed
Capital increase The capital rose from €25,000 to €979,000 · The capital rose from €25,000 to €89,000, with 64 new shares · The capital rose from €89,000 to €979,000 · General meeting of 31-12-2013 · Gazette deed
Incorporation published on 21-04-2006 · Gazette deed
All 36 events

Comparable companies

same main activity, similar in size and age
Company
Dr. E. MULLIEZ Ypres €3.6m €530,534 88.5% -
DOKTER PHILIPPE CLARYSSE Kortrijk €3.6m €557,750 89.9% -
DR. VANDERKERKEN - DR. DECRAENE Sint-Truiden €3.3m €558,632 59.8% 0.8
SOLI-ST Virton €3.5m €533,331 84.7% -
Dokter Marc Coenen Gynaecologie Sint-Niklaas €3.5m €500,262 81.5% 1
CARDIAC CARE Beersel €3.2m €558,781 85.1% -
Dr. A. Demeyere Keerbergen €4.0m €475,368 96.1% -

These companies have the same main activity as Dr. E. MULLIEZ: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €3.2m and €4m, founded between 2002 and 2005.

Official details

Source: KBO
Status
Active since 11-04-2006Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.275.344.4408900 Ypres, since 11-04-2006
Financial year end
28 February
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 28-02-2026

≈ €800,000estimated
€3.6m▼ 0.5%
Filing
Filed on 28-09-2026, 2 days before the end of the filing period
Financials

Insights on Dr. E. MULLIEZ

Dr. E. MULLIEZ files the micro format. That format states no turnover. The gross margin fell from €555,762 in 2008 to €530,534 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. E. MULLIEZ

What is the company number of Dr. E. MULLIEZ?
The company number of Dr. E. MULLIEZ is 0880.650.726. The VAT number is the same number with BE in front: BE 0880.650.726.
Where is Dr. E. MULLIEZ based?
The registered office is at Rijselstraat 88, 8900 Ypres.Company details
What does Dr. E. MULLIEZ do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. E. MULLIEZ?
Dr. E. MULLIEZ is a private limited company (BV).
When was Dr. E. MULLIEZ founded?
Dr. E. MULLIEZ was founded on 11-04-2006.
Is Dr. E. MULLIEZ still active?
Yes, Dr. E. MULLIEZ is an active enterprise in the KBO register.
What is the turnover of Dr. E. MULLIEZ?
The turnover in financial year 2026 is ≈ €800,000. This figure is estimated from the gross margin of €530,534 and 31 comparable companies (NACE 86220). It probably lies between €710,000 and €1.1m.Financials
Is Dr. E. MULLIEZ profitable?
In financial year 2026, Dr. E. MULLIEZ made a profit of €386,245.
Where can I find the annual accounts of Dr. E. MULLIEZ?
Dr. E. MULLIEZ filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of Dr. E. MULLIEZ due?
Dr. E. MULLIEZ must file the annual accounts for financial year 2027 by 30-09-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.